Zilucoplan levels in breast milk of healthy nursing mothers
Treatments studied
This study measures how much of the drug zilucoplan passes into breast milk. Healthy nursing mothers who are already planning to stop breastfeeding can take part to help understand how the drug is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are healthy, nursing, and at least 6 weeks after giving birth
- You are already planning to stop breastfeeding
- You agree to stop breastfeeding before the study starts and not to resume or donate breast milk for this period
- You have received meningococcal vaccines at least 2 weeks before taking the study drug
- You do not have certain serious health conditions or recent infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives an injectable medicine called zilucoplan to children who were part of an earlier trial and could benefit from more treatment. It aims to see if zilucoplan is safe and helpful for young patients with generalized myasthenia gravis.
This study tests a new daily shot (zilucoplan) for children and teens with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. It aims to see if the drug is safe and helps improve strength and daily functioning.
This study measures how much of the medication mirikizumab passes into breast milk when mothers take it for their approved medical condition. The goal is to understand if it's safe for breastfeeding infants when mothers are receiving this treatment.
This study checks how much of an antibiotic called fosfomycin passes into breast milk when given intravenously to healthy nursing mothers. The goal is to understand if it's safe for breastfeeding women to receive this antibiotic.
This trial tests zilucoplan, a daily injection, to treat severe muscle weakness from myasthenia gravis that requires hospital care. It may help you recover faster and avoid needing a breathing tube.
This trial tests how much of the drug nipocalimab gets into breast milk. It is for healthy women who are currently breastfeeding their baby.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.